112 related articles for article (PubMed ID: 23413704)
1. Relationship between total thiol status and thrombocytopenia in patients with Crimean-Congo hemorrhagic fever.
Guner R; Tasyaran MA; Keske S; Hasanoglu I; Kalem AK; Yapar D; Gulen TA; Neselioglu S; Isikoglu S; Erel O
Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1411-8. PubMed ID: 23413704
[TBL] [Abstract][Full Text] [Related]
2. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.
Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ
Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857
[TBL] [Abstract][Full Text] [Related]
3. Plasma oxidative stress and total thiol levels in Crimean-Congo hemorrhagic fever.
Karadag-Oncel E; Erel O; Ozsurekci Y; Caglayik DY; Kaya A; Gozel MG; Icagasioglu FD; Engin A; Korukluoglu G; Uyar Y; Elaldi N; Ceyhan M
Jpn J Infect Dis; 2014; 67(1):22-6. PubMed ID: 24451097
[TBL] [Abstract][Full Text] [Related]
4. Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion?
Barut S; Dincer F; Sahin I; Ozyurt H; Akkus M; Erkorkmaz U
Int J Infect Dis; 2010 Jan; 14(1):e50-4. PubMed ID: 19487150
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the serum levels of soluble IL-2 receptor and endothelin-1 in children with Crimean-Congo hemorrhagic fever.
Deveci K; Oflaz MB; Sancakdar E; Uysal EB; Guven AS; Kaya A; Alkan F; Cevit O
APMIS; 2014 Jul; 122(7):643-7. PubMed ID: 24320760
[TBL] [Abstract][Full Text] [Related]
6. Clinical investigation of the transient evoked otoacoustic emission test in Crimean-Congo hemorrhagic fever.
Engin A; Yildirim A; Kunt T; Bakir M; Dokmetas I; Ozdemir L
Int J Infect Dis; 2008 Mar; 12(2):162-5. PubMed ID: 17714968
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever.
Menteşe A; Yilmaz G; Sümer A; Arslan M; Karahan SC; Köksal I
Int J Infect Dis; 2013 Nov; 17(11):e1042-5. PubMed ID: 23632301
[TBL] [Abstract][Full Text] [Related]
8. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever.
Bodur H; Akinci E; Ongürü P; Uyar Y; Baştürk B; Gözel MG; Kayaaslan BU
Int J Infect Dis; 2010 Aug; 14(8):e704-7. PubMed ID: 20627646
[TBL] [Abstract][Full Text] [Related]
9. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever.
Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
Scand J Infect Dis; 2010 May; 42(5):385-8. PubMed ID: 20095935
[TBL] [Abstract][Full Text] [Related]
10. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
11. A retrospective controlled study of thiol disulfide homeostasis as a novel marker in Crimean Congo hemorrhagic fever.
Tufan ZK; Hasanoglu I; Kolgelier S; Alisik M; Ergin M; Yilmaz GR; Tasyaran MA; Erel O; Guner R
Redox Rep; 2017 Nov; 22(6):241-245. PubMed ID: 27159644
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
13. High-dose methylprednisolone in children with Crimean-Congo haemorrhagic fever.
Dilber E; Cakir M; Erduran E; Koksal I; Bahat E; Mutlu M; Celtik AY; Okten A
Trop Doct; 2010 Jan; 40(1):27-30. PubMed ID: 20075424
[TBL] [Abstract][Full Text] [Related]
14. Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever.
Sonmez M; Aydin K; Durmus A; Sucu N; Yilmaz M; Akdogan E; Koksal I; Ovali E; Omay SB
J Infect; 2007 Aug; 55(2):184-7. PubMed ID: 17418898
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of Mannan-binding lectin in patients with Crimean-Congo hemorrhagic fever.
Engin A; Ugurlu S; Caglar E; Oztop AY; Inan D; Elaldi N; Dokmetas I; Bakir M
Vector Borne Zoonotic Dis; 2010 Dec; 10(10):1037-41. PubMed ID: 20426687
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
Bakir M; Bakir S; Sari I; Celik VK; Gozel MG; Engin A
J Med Virol; 2013 Oct; 85(10):1794-801. PubMed ID: 23868816
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase I-II autoantibodies and oxidative status in long-term follow-up of patients with Crimean-Congo haemorrhagic fever.
Yilmaz H; Kostakoğlu U; Demir S; Aksoy F; Menteşe A; Karahan SC; Köksal İ; Alver A; Yilmaz G
Arch Physiol Biochem; 2018 Feb; 124(1):69-74. PubMed ID: 28796539
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
[TBL] [Abstract][Full Text] [Related]
20. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
Ertugrul B; Uyar Y; Yavas K; Turan C; Oncu S; Saylak O; Carhan A; Ozturk B; Erol N; Sakarya S
Int J Infect Dis; 2009 Nov; 13(6):e431-6. PubMed ID: 19409826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
